MANNKIND CORP Debt Instrument, Decrease, Forgiveness
MANNKIND CORP (MNKD) reported Debt Instrument, Decrease, Forgiveness of $10.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2026-02-26
- MANNKIND CORP debt instrument, decrease, forgiveness for the quarter ending 2021-12-31 was $0.00.
- MANNKIND CORP debt instrument, decrease, forgiveness for fiscal 2025 was $10.00M.
- MANNKIND CORP debt instrument, decrease, forgiveness for fiscal 2021 was $4.87M.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 9 month | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|---|---|
| 2025-12-31 | $10.00M 10-K · filed 2026-02-26 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.87M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $4.87M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |